Short Interest in Evoke Pharma, Inc. (NASDAQ:EVOK) Declines By 83.2%

Evoke Pharma, Inc. (NASDAQ:EVOK – Get Free Report) was the target of a significant drop in short interest in November. As of November 15th, there was short interest totalling 17,000 shares, a drop of 83.2% from the October 31st total of 101,000 shares. Approximately 1.3% of the shares of the stock are sold short. Based […]

Leave a Reply

Your email address will not be published.

Previous post Insider Selling: Quaker Chemical Co. (NYSE:KWR) EVP Sells $107,057.10 in Stock
Next post Brown & Brown, Inc. (NYSE:BRO) Stake Boosted by BNP Paribas Financial Markets